Ken Griffin Evolus, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Evolus, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 36,800 shares of EOLS stock, worth $551,264. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,800

Previous 74,700 50.74%

Holding current value

$551,264

Previous $1.05 Million 61.82%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.45 - $13.76 $14,985 - $19,731	1,434 Added 2.29%	64,116 $695,000
Q1 2024 May 15, 2024	SELL	$9.99 - $14.91 $1.08 Million - $1.62 Million	-108,534 Reduced 63.39%	62,682 $877,000
Q4 2023 Feb 14, 2024	BUY	$7.6 - $10.53 $1.03 Million - $1.43 Million	136,141 Added 388.14%	171,216 $1.8 Million
Q3 2023 Nov 14, 2023	SELL	$7.15 - $10.2 $1.92 Million - $2.74 Million	-268,605 Reduced 88.45%	35,075 $320,000
Q2 2023 Aug 14, 2023	BUY	$7.23 - $10.52 $860,073 - $1.25 Million	118,959 Added 64.4%	303,680 $2.21 Million
Q1 2023 May 15, 2023	BUY	$7.81 - $11.05 $866,417 - $1.23 Million	110,937 Added 150.35%	184,721 $1.56 Million
Q4 2022 Feb 14, 2023	SELL	$6.52 - $8.95 $893,592 - $1.23 Million	-137,054 Reduced 65.0%	73,784 $554,000
Q3 2022 Nov 14, 2022	SELL	$7.76 - $13.72 $1.82 Million - $3.23 Million	-235,065 Reduced 52.72%	210,838 $1.7 Million
Q2 2022 Aug 15, 2022	BUY	$10.22 - $13.94 $1.99 Million - $2.71 Million	194,302 Added 77.23%	445,903 $5.17 Million
Q1 2022 May 16, 2022	BUY	$5.22 - $11.78 $649,060 - $1.46 Million	124,341 Added 97.71%	251,601 $2.82 Million
Q4 2021 Feb 14, 2022	SELL	$5.37 - $8.38 $1.43 Million - $2.24 Million	-266,894 Reduced 67.71%	127,260 $828,000
Q3 2021 Nov 15, 2021	BUY	$7.36 - $13.67 $1.67 Million - $3.09 Million	226,287 Added 134.8%	394,154 $3 Million
Q2 2021 Aug 16, 2021	BUY	$8.42 - $13.96 $1.02 Million - $1.69 Million	121,393 Added 261.21%	167,867 $2.12 Million
Q1 2021 May 17, 2021	BUY	$3.2 - $16.51 $89,968 - $464,178	28,115 Added 153.14%	46,474 $604,000
Q4 2020 Feb 16, 2021	BUY	$2.92 - $4.84 $4,558 - $7,555	1,561 Added 9.29%	18,359 $62,000
Q3 2020 Nov 16, 2020	BUY	$3.03 - $5.48 $20,285 - $36,688	6,695 Added 66.27%	16,798 $66,000
Q1 2020 May 15, 2020	SELL	$3.53 - $12.21 $3 Million - $10.4 Million	-849,401 Reduced 98.82%	10,103 $42,000
Q4 2019 Feb 14, 2020	BUY	$11.58 - $17.37 $9.47 Million - $14.2 Million	817,470 Added 1944.78%	859,504 $10.5 Million
Q2 2019 Aug 14, 2019	BUY	$13.19 - $28.36 $146,659 - $315,334	11,119 Added 35.97%	42,034 $615,000
Q1 2019 May 15, 2019	BUY	$12.43 - $28.91 $241,440 - $561,547	19,424 Added 169.04%	30,915 $0
Q4 2018 Feb 14, 2019	SELL	$10.57 - $19.29 $1.7 Million - $3.1 Million	-160,594 Reduced 93.32%	11,491 $136,000
Q1 2018 May 11, 2018	BUY	$8.34 - $12.5 $1.44 Million - $2.15 Million	172,085 New	172,085 $1.55 Million

Others Institutions Holding EOLS

# of Institutions

163

Shares Held

49.1M

Call Options Held

453K

Put Options Held

14K

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $840M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account